Comparison of assessment of oxygen consumption, Etest, and CLSI M38-A2 broth microdilution methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 11, 2009, Pages 4921-4923

  Araujo, Ricardo ^a,b   Espinel Ingroff, Ana ^c  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POSACONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BROTH DILUTION; CONTROLLED STUDY; EPSILOMETER TEST; FUNGAL STRAIN; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; DRUG RESISTANCE, FUNGAL; MICROBIAL SENSITIVITY TESTS; OXYGEN CONSUMPTION; TRIAZOLES;

EID: 70350331089     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00862-09     Document Type: Article

References (17)

1. Antachopoulos, C., J. Meletiadis, T. Sein, E. Roilides, and T. J. Walsh. 2007. Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species. J. Antimicrob. Chemother. 59:230-237. (Pubitemid 47072062)
2. Araujo, R., C. Pina-Vaz, A. G. Rodrigues, A. Amorim, and L. Gusmão. 2009. Simple and highly discriminatory microsatellite based multiplex PCR for Aspergillus fumigatus strain typing. Clin. Microbiol. Infect. 15:260-266.
3. Araujo, R., I. Coutinho, and A. Espinel-Ingroff. 2008. Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption. J. Antimicrob. Chemother. 62:1277-1280.
4. Arendrup, M. C., S. Perkhofer, S. J. Howard, G. Garcia-Effron, A. Vishukumar, D. Perlin, and C. Lass-Flörl. 2008. Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins. Antimicrob. Agents Chemother. 52:3504-3511.
5. Barry, A. L., M. A. Pfaller, S. D. Brown, A. Espinel-Ingroff, M. A. Ghannoum, C. Knapp, R. P. Rennie, J. H. Rex, and M. G. Rinaldi. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459.
6. Chryssanthou, E., and M. Cuenca-Estrella. 2006. Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp. Clin. Microbiol. Infect. 12:901-904. (Pubitemid 44151291)
7. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungals susceptibility testing of conidium-forming filamentous fungi: approved standard, 2nd ed. M38-A2. CLSI, Wayne, PA.
8. De Lucca, A. J., T. J. Walsh, and D. J. Daigle. 1996. N-Acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp. Antimicrob. Agents Chemother. 40:1274-1276. (Pubitemid 26136049)
9. Espinel-Ingroff, A., and A. Rezusta. 2002. E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J. Clin. Microbiol. 40:2101-2107.
10. Garcia-Effron, G., A. Dilger, L. Alcazar-Fuoli, S. Park, E. Mellado, and D. S. Perlin. 2008. Rapid detection of triazole antifungal resistance in Aspergillus fumigatus. J. Clin. Microbiol. 46:1200-1206.
11. Lass-Florl, C., G. Kofler, G. Kropshofer, J. Hermans, A. Kreczy, M. P. Dierich, and D. Niederwieser. 1998. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J. Antimicrob. Chemother. 42:497-502.
12. Latge, J. P. 2001. The pathobiology of Aspergillus fumigatus. Trends Microbiol. 9:382-389.
13. Mann, P. A., R. M. Parmegiani, S. Q. Wei, C. A. Mendrick, X. Li, D. Loebenberg, B. DiDomenico, R. S. Hare, S. S. Walker, and P. M. McNicholas. 2003. Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14α-demethylase. Antimicrob. Agents Chemother. 47:577-581.
14. Pfaller, M. A., S. A. Messer, L. Boyken, R. J. Hollis, and D. J. Diekema. 2003. In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs. Diagn. Microbiol. Infect. Dis. 45:241-244.
15. Rodriguez-Tudela, J. L., L. Alcazar-Fuoli, E. Mellado, A. Alastruey-Izquierdo, A. Monzon, and M. Cuenca-Estrella. 2008. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 52:2468-2472.
16. Schiller, D. S., and H. B. Fung. 2007. Posaconazole: an extended-spectrum triazole antifungal agent. Clin. Ther. 29:1862-1886.
17. Snelders, E., H. A. van der Lee, J. Kuijpers, A. J. Rijs, J. Varga, R. A. Samson, E. Mellado, A. R. Donders, W. J. Melchers, and P. E. Verweij. 2008. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 5:e219.